

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.51709770 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39004442 |
| 3 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.24183724 |
| 4 | response to muramyl dipeptide (GO:0032495) | 4.21222889 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.20086165 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06641822 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.01120909 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00441048 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.00441048 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98752891 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.98752891 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98752891 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.98752891 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98752891 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98752891 |
| 16 | microglial cell activation (GO:0001774) | 3.95154261 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91372889 |
| 18 | activation of MAPKKK activity (GO:0000185) | 3.88667695 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 3.78935082 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.75414313 |
| 21 | T-helper 1 type immune response (GO:0042088) | 3.74008381 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.67666929 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.67666929 |
| 24 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.65522188 |
| 25 | tolerance induction (GO:0002507) | 3.59378202 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.52718200 |
| 27 | positive thymic T cell selection (GO:0045059) | 3.44424175 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43524448 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 3.38418165 |
| 30 | response to protozoan (GO:0001562) | 3.36933170 |
| 31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.31917687 |
| 32 | positive regulation of chemokine secretion (GO:0090197) | 3.26344803 |
| 33 | myeloid dendritic cell differentiation (GO:0043011) | 3.26342115 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26323768 |
| 35 | cellular extravasation (GO:0045123) | 3.25934381 |
| 36 | detection of other organism (GO:0098543) | 3.24725532 |
| 37 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.17089894 |
| 38 | defense response to protozoan (GO:0042832) | 3.16144978 |
| 39 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.14914403 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.14468279 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14410565 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.14332646 |
| 43 | detection of bacterium (GO:0016045) | 3.13694422 |
| 44 | cellular response to arsenic-containing substance (GO:0071243) | 3.13587215 |
| 45 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.11264866 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.10775494 |
| 47 | negative regulation of granulocyte differentiation (GO:0030853) | 3.09544450 |
| 48 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08125943 |
| 49 | myeloid dendritic cell activation (GO:0001773) | 3.07702023 |
| 50 | positive regulation of interferon-alpha production (GO:0032727) | 3.06580704 |
| 51 | mature B cell differentiation (GO:0002335) | 3.06481062 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.05586771 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.04541705 |
| 54 | leukocyte aggregation (GO:0070486) | 3.01814008 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 3.00282454 |
| 56 | regulation of podosome assembly (GO:0071801) | 2.98971387 |
| 57 | response to laminar fluid shear stress (GO:0034616) | 2.98873102 |
| 58 | regulation of interferon-alpha production (GO:0032647) | 2.97698970 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 2.96808911 |
| 60 | macrophage activation (GO:0042116) | 2.91963883 |
| 61 | regulation of antigen processing and presentation (GO:0002577) | 2.91333127 |
| 62 | neutrophil activation (GO:0042119) | 2.90914096 |
| 63 | granulocyte activation (GO:0036230) | 2.88696367 |
| 64 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87950140 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 2.84800561 |
| 66 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84321934 |
| 67 | negative thymic T cell selection (GO:0045060) | 2.83733898 |
| 68 | regulation of B cell differentiation (GO:0045577) | 2.81717364 |
| 69 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.78584986 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.77581882 |
| 71 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.77192327 |
| 72 | regulation of chemokine biosynthetic process (GO:0045073) | 2.77174391 |
| 73 | thymic T cell selection (GO:0045061) | 2.76321979 |
| 74 | dendritic cell differentiation (GO:0097028) | 2.74900989 |
| 75 | germinal center formation (GO:0002467) | 2.74891476 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74760382 |
| 77 | detection of molecule of bacterial origin (GO:0032490) | 2.74171000 |
| 78 | negative T cell selection (GO:0043383) | 2.73821895 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.73488384 |
| 80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73487456 |
| 81 | positive regulation of humoral immune response (GO:0002922) | 2.73098472 |
| 82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.71012044 |
| 83 | detection of external biotic stimulus (GO:0098581) | 2.70759519 |
| 84 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.70506340 |
| 85 | negative regulation of interleukin-6 production (GO:0032715) | 2.70402228 |
| 86 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.70288255 |
| 87 | positive T cell selection (GO:0043368) | 2.70231702 |
| 88 | positive regulation of type 2 immune response (GO:0002830) | 2.70062581 |
| 89 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.69452682 |
| 90 | positive regulation of p38MAPK cascade (GO:1900745) | 2.69345316 |
| 91 | regulation of chronic inflammatory response (GO:0002676) | 2.69175561 |
| 92 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.67840660 |
| 93 | response to peptidoglycan (GO:0032494) | 2.67122386 |
| 94 | regulation of chemokine secretion (GO:0090196) | 2.65417163 |
| 95 | positive regulation of interleukin-12 production (GO:0032735) | 2.64377363 |
| 96 | T cell migration (GO:0072678) | 2.64154198 |
| 97 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64113814 |
| 98 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.63898187 |
| 99 | response to interleukin-15 (GO:0070672) | 2.63640558 |
| 100 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.62573755 |
| 101 | growth hormone receptor signaling pathway (GO:0060396) | 2.61889660 |
| 102 | embryonic process involved in female pregnancy (GO:0060136) | 2.60163878 |
| 103 | I-kappaB phosphorylation (GO:0007252) | 2.58167885 |
| 104 | interferon-gamma production (GO:0032609) | 2.57235402 |
| 105 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.56537690 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.56004909 |
| 107 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55626536 |
| 108 | regulation of tolerance induction (GO:0002643) | 2.54569498 |
| 109 | myeloid leukocyte activation (GO:0002274) | 2.54213778 |
| 110 | cellular response to interferon-gamma (GO:0071346) | 2.54186275 |
| 111 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53557011 |
| 112 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.53414812 |
| 113 | B cell mediated immunity (GO:0019724) | 2.53168338 |
| 114 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52878384 |
| 115 | positive regulation of interleukin-2 production (GO:0032743) | 2.52477575 |
| 116 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.52375426 |
| 117 | B cell homeostasis (GO:0001782) | 2.52189995 |
| 118 | regulation of interleukin-12 production (GO:0032655) | 2.52055326 |
| 119 | T cell selection (GO:0045058) | 2.52032252 |
| 120 | cellular response to lipopolysaccharide (GO:0071222) | 2.51708366 |
| 121 | protein localization to endosome (GO:0036010) | 2.51666982 |
| 122 | leukocyte cell-cell adhesion (GO:0007159) | 2.51231754 |
| 123 | regulation of T-helper cell differentiation (GO:0045622) | 2.51153629 |
| 124 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.49383903 |
| 125 | respiratory burst (GO:0045730) | 2.48412614 |
| 126 | response to type I interferon (GO:0034340) | 2.47546247 |
| 127 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.47293859 |
| 128 | response to host (GO:0075136) | 2.47293859 |
| 129 | response to host defenses (GO:0052200) | 2.47293859 |
| 130 | cellular response to interleukin-15 (GO:0071350) | 2.47100868 |
| 131 | germ cell migration (GO:0008354) | 2.46599572 |
| 132 | regulation of monocyte differentiation (GO:0045655) | 2.44891303 |
| 133 | cellular response to type I interferon (GO:0071357) | 2.44114479 |
| 134 | type I interferon signaling pathway (GO:0060337) | 2.44114479 |
| 135 | positive regulation of tolerance induction (GO:0002645) | 2.43734895 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.43083117 |
| 137 | response to host immune response (GO:0052572) | 2.43083117 |
| 138 | hepatocyte apoptotic process (GO:0097284) | 2.40612916 |
| 139 | negative regulation of bone resorption (GO:0045779) | 2.39696442 |
| 140 | positive regulation of macrophage differentiation (GO:0045651) | 2.38795678 |
| 141 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.38224578 |
| 142 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.36767103 |
| 143 | natural killer cell differentiation (GO:0001779) | 2.35903240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.27955350 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.30404536 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.16632379 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.12006695 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.84015612 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.63676079 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.24595561 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.20874707 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16900662 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.15056173 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.83758639 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68349678 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61249432 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.52576319 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52059899 |
| 16 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51534271 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.35381318 |
| 18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28541298 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27109000 |
| 20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.18225175 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.17742833 |
| 22 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.16235703 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10316753 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09318929 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08471497 |
| 26 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06873130 |
| 27 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.00875980 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 1.98785734 |
| 29 | * MYB_26560356_Chip-Seq_TH2_Human | 1.97816738 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97213010 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94898959 |
| 32 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.92850738 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92097116 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91209618 |
| 35 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85669122 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85112348 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84955387 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84784669 |
| 39 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78023193 |
| 40 | * MYB_26560356_Chip-Seq_TH1_Human | 1.69916596 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67184610 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66735269 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65972351 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65651963 |
| 45 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.64264618 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63884790 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63485112 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58273167 |
| 49 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55773805 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51906544 |
| 51 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47455954 |
| 52 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.41316054 |
| 53 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.39196086 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33563456 |
| 55 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.33033137 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31317943 |
| 57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31317889 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29748453 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29682050 |
| 60 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28454268 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27839825 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27686170 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24565185 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24512989 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22271603 |
| 66 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19975356 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.17543622 |
| 68 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17095301 |
| 69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15294545 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.14110758 |
| 71 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13882688 |
| 72 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13882688 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.13308074 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13182387 |
| 75 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12593769 |
| 76 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11353445 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11294694 |
| 78 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08713460 |
| 79 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06854145 |
| 80 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06684327 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05479440 |
| 82 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05408977 |
| 83 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.04738580 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04223092 |
| 85 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03641353 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03292249 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01638595 |
| 88 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01412566 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00980422 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99597129 |
| 91 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99232669 |
| 92 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99168491 |
| 93 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99156763 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98895926 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98680517 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98545793 |
| 97 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98439895 |
| 98 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98012195 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97975251 |
| 100 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.97642028 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97627928 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96361065 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95689897 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95092391 |
| 105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93631299 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93589814 |
| 107 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93452546 |
| 108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92366035 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91855860 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91641506 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91434583 |
| 112 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90639471 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90094898 |
| 114 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.89930478 |
| 115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89214324 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86265354 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84956241 |
| 118 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84507888 |
| 119 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83004494 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82887467 |
| 121 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82500051 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82172069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.19613964 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.59705455 |
| 3 | MP0004510_myositis | 3.52124408 |
| 4 | MP0003436_decreased_susceptibility_to | 2.90493797 |
| 5 | MP0000685_abnormal_immune_system | 2.82631847 |
| 6 | MP0005387_immune_system_phenotype | 2.81291096 |
| 7 | MP0001790_abnormal_immune_system | 2.81291096 |
| 8 | MP0005671_abnormal_response_to | 2.76582984 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.73133508 |
| 10 | MP0001800_abnormal_humoral_immune | 2.69916295 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.60991596 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.58132773 |
| 13 | MP0006082_CNS_inflammation | 2.54141521 |
| 14 | MP0003724_increased_susceptibility_to | 2.52161249 |
| 15 | MP0002723_abnormal_immune_serum | 2.42775184 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.36598384 |
| 17 | MP0002419_abnormal_innate_immunity | 2.34684347 |
| 18 | MP0009785_altered_susceptibility_to | 2.28134821 |
| 19 | MP0001819_abnormal_immune_cell | 2.24233983 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.23254474 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.19524050 |
| 22 | MP0004947_skin_inflammation | 2.10858457 |
| 23 | MP0005025_abnormal_response_to | 2.10228775 |
| 24 | MP0005451_abnormal_body_composition | 2.08838578 |
| 25 | MP0002405_respiratory_system_inflammati | 1.97156432 |
| 26 | MP0002254_reproductive_system_inflammat | 1.92069458 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.88220285 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.82678583 |
| 29 | MP0002006_tumorigenesis | 1.82308996 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.81297377 |
| 31 | MP0001853_heart_inflammation | 1.80358943 |
| 32 | MP0003828_pulmonary_edema | 1.78262587 |
| 33 | MP0009840_abnormal_foam_cell | 1.78008264 |
| 34 | MP0001873_stomach_inflammation | 1.76901045 |
| 35 | MP0009278_abnormal_bone_marrow | 1.73468846 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.71416162 |
| 37 | MP0002398_abnormal_bone_marrow | 1.70647330 |
| 38 | MP0000716_abnormal_immune_system | 1.70569422 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.65152409 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.64822446 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.64634446 |
| 42 | MP0002933_joint_inflammation | 1.62293389 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.54753469 |
| 44 | MP0001851_eye_inflammation | 1.52307126 |
| 45 | MP0003091_abnormal_cell_migration | 1.50547813 |
| 46 | MP0008260_abnormal_autophagy | 1.49581940 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.48810499 |
| 48 | MP0005310_abnormal_salivary_gland | 1.47411344 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.46419659 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.43647157 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.42500347 |
| 52 | MP0003448_altered_tumor_morphology | 1.41275574 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.40728043 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.39465460 |
| 55 | MP0003279_aneurysm | 1.38653997 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.37704529 |
| 57 | MP0003075_altered_response_to | 1.37427969 |
| 58 | MP0002722_abnormal_immune_system | 1.34898854 |
| 59 | MP0002429_abnormal_blood_cell | 1.33951259 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.28288087 |
| 61 | MP0000343_altered_response_to | 1.27230655 |
| 62 | MP0003045_fibrosis | 1.26499465 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.25380689 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.23954123 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.23954123 |
| 66 | MP0002009_preneoplasia | 1.23805965 |
| 67 | MP0000858_altered_metastatic_potential | 1.18582189 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.17017988 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.16612151 |
| 70 | MP0000767_abnormal_smooth_muscle | 1.16327310 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.11323812 |
| 72 | MP0005390_skeleton_phenotype | 1.09989537 |
| 73 | MP0008469_abnormal_protein_level | 1.07108082 |
| 74 | MP0005023_abnormal_wound_healing | 1.05130342 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.01474193 |
| 76 | MP0005166_decreased_susceptibility_to | 1.00945558 |
| 77 | MP0003705_abnormal_hypodermis_morpholog | 0.99685177 |
| 78 | MP0000249_abnormal_blood_vessel | 0.99147358 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.98001246 |
| 80 | MP0009764_decreased_sensitivity_to | 0.97649325 |
| 81 | MP0008438_abnormal_cutaneous_collagen | 0.96956112 |
| 82 | MP0008004_abnormal_stomach_pH | 0.96256285 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 0.95660159 |
| 84 | MP0003866_abnormal_defecation | 0.93222327 |
| 85 | MP0002796_impaired_skin_barrier | 0.90514582 |
| 86 | MP0002396_abnormal_hematopoietic_system | 0.90434329 |
| 87 | MP0001879_abnormal_lymphatic_vessel | 0.90339556 |
| 88 | MP0001958_emphysema | 0.90249676 |
| 89 | MP0002928_abnormal_bile_duct | 0.86027071 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.84811881 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.83352307 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.82310302 |
| 93 | MP0005275_abnormal_skin_tensile | 0.81925826 |
| 94 | MP0005164_abnormal_response_to | 0.79904881 |
| 95 | MP0003795_abnormal_bone_structure | 0.79700122 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.78631299 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78396325 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.78321596 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.77966091 |
| 100 | MP0004381_abnormal_hair_follicle | 0.77658391 |
| 101 | MP0000733_abnormal_muscle_development | 0.75824236 |
| 102 | MP0009931_abnormal_skin_appearance | 0.74404626 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.73615909 |
| 104 | MP0009763_increased_sensitivity_to | 0.73476287 |
| 105 | MP0002132_abnormal_respiratory_system | 0.71386841 |
| 106 | MP0000604_amyloidosis | 0.71007234 |
| 107 | MP0008007_abnormal_cellular_replicative | 0.70781315 |
| 108 | MP0004883_abnormal_blood_vessel | 0.70661983 |
| 109 | MP0002060_abnormal_skin_morphology | 0.69926848 |
| 110 | MP0005621_abnormal_cell_physiology | 0.69748855 |
| 111 | MP0001663_abnormal_digestive_system | 0.68137872 |
| 112 | MP0010307_abnormal_tumor_latency | 0.67906818 |
| 113 | MP0005501_abnormal_skin_physiology | 0.66754566 |
| 114 | MP0001542_abnormal_bone_strength | 0.65436781 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.65436664 |
| 116 | MP0000490_abnormal_crypts_of | 0.64607442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.12070423 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.75030256 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.43010958 |
| 4 | Hematochezia (HP:0002573) | 4.20125107 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.78485404 |
| 6 | Stomatitis (HP:0010280) | 3.72492446 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 3.65982918 |
| 8 | Cerebral aneurysm (HP:0004944) | 3.65591499 |
| 9 | Myositis (HP:0100614) | 3.59841591 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.58713025 |
| 11 | Colitis (HP:0002583) | 3.56801893 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.18950296 |
| 13 | Inflammation of the large intestine (HP:0002037) | 3.16976247 |
| 14 | Arterial tortuosity (HP:0005116) | 3.16516146 |
| 15 | Cellulitis (HP:0100658) | 3.14251342 |
| 16 | Increased IgE level (HP:0003212) | 3.12142767 |
| 17 | Glomerulonephritis (HP:0000099) | 3.09977210 |
| 18 | Recurrent skin infections (HP:0001581) | 3.07884437 |
| 19 | Orchitis (HP:0100796) | 3.06298568 |
| 20 | Recurrent viral infections (HP:0004429) | 3.05981560 |
| 21 | Aortic aneurysm (HP:0004942) | 2.97466858 |
| 22 | Chronic otitis media (HP:0000389) | 2.97041920 |
| 23 | Myocardial infarction (HP:0001658) | 2.96385328 |
| 24 | Vascular tortuosity (HP:0004948) | 2.94365073 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94330096 |
| 26 | Gastrointestinal inflammation (HP:0004386) | 2.94128877 |
| 27 | Interstitial pulmonary disease (HP:0006530) | 2.93575569 |
| 28 | Spontaneous hematomas (HP:0007420) | 2.92138897 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.90673961 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.90673961 |
| 31 | Optic neuritis (HP:0100653) | 2.83930279 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.83930279 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.74419428 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.74419428 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74419428 |
| 36 | Aortic dissection (HP:0002647) | 2.72574825 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.68637344 |
| 38 | Vasculitis (HP:0002633) | 2.65857741 |
| 39 | Obstructive lung disease (HP:0006536) | 2.65768422 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65768422 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.62120622 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.61685442 |
| 43 | Arterial thrombosis (HP:0004420) | 2.61103388 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.60687524 |
| 45 | Nasal polyposis (HP:0100582) | 2.52659739 |
| 46 | IgA deficiency (HP:0002720) | 2.52054464 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.51880633 |
| 48 | Increased density of long bones (HP:0006392) | 2.47161752 |
| 49 | Mitral valve prolapse (HP:0001634) | 2.45986827 |
| 50 | Meningitis (HP:0001287) | 2.45332425 |
| 51 | Emphysema (HP:0002097) | 2.44540288 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.43732269 |
| 53 | Gingivitis (HP:0000230) | 2.36779605 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.35579080 |
| 55 | Dysostosis multiplex (HP:0000943) | 2.35076148 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33559027 |
| 57 | Hypertensive crisis (HP:0100735) | 2.33355774 |
| 58 | Pustule (HP:0200039) | 2.32361554 |
| 59 | Distal lower limb muscle weakness (HP:0009053) | 2.29768330 |
| 60 | Chronic diarrhea (HP:0002028) | 2.29374105 |
| 61 | Restrictive lung disease (HP:0002091) | 2.27297691 |
| 62 | Peritonitis (HP:0002586) | 2.26947741 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.24731178 |
| 64 | Urticaria (HP:0001025) | 2.23330578 |
| 65 | Leukocytosis (HP:0001974) | 2.22931614 |
| 66 | Thick nail (HP:0001805) | 2.22930463 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.21289405 |
| 68 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.20996861 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.20996861 |
| 70 | Petechiae (HP:0000967) | 2.20967679 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.18781224 |
| 72 | Fatigue (HP:0012378) | 2.18406092 |
| 73 | Osteomyelitis (HP:0002754) | 2.18264416 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18041401 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.17758619 |
| 76 | Axonal loss (HP:0003447) | 2.15812567 |
| 77 | Dilatation of the ascending aorta (HP:0005111) | 2.13782781 |
| 78 | Hemoptysis (HP:0002105) | 2.13615448 |
| 79 | Spondylolisthesis (HP:0003302) | 2.13485875 |
| 80 | Increased IgM level (HP:0003496) | 2.13330404 |
| 81 | Deep palmar crease (HP:0006191) | 2.10909255 |
| 82 | Persistence of primary teeth (HP:0006335) | 2.09967209 |
| 83 | Syringomyelia (HP:0003396) | 2.09651229 |
| 84 | Spinal cord lesions (HP:0100561) | 2.09651229 |
| 85 | Eosinophilia (HP:0001880) | 2.09122756 |
| 86 | Abnormality of nail color (HP:0100643) | 2.08372291 |
| 87 | Sparse lateral eyebrow (HP:0005338) | 2.07834073 |
| 88 | Thrombocytosis (HP:0001894) | 2.06415267 |
| 89 | Premature rupture of membranes (HP:0001788) | 2.05478525 |
| 90 | Nephritis (HP:0000123) | 2.05361519 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.03371286 |
| 92 | IgM deficiency (HP:0002850) | 2.02795510 |
| 93 | Disinhibition (HP:0000734) | 2.02327273 |
| 94 | Hypergammaglobulinemia (HP:0010702) | 2.01728169 |
| 95 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00881934 |
| 96 | Gangrene (HP:0100758) | 2.00583120 |
| 97 | Striae distensae (HP:0001065) | 1.96496944 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 1.93100454 |
| 99 | Chronic sinusitis (HP:0011109) | 1.92403148 |
| 100 | Nuclear cataract (HP:0100018) | 1.91311915 |
| 101 | Thin bony cortex (HP:0002753) | 1.91027122 |
| 102 | Abnormal platelet function (HP:0011869) | 1.90618186 |
| 103 | Impaired platelet aggregation (HP:0003540) | 1.90618186 |
| 104 | Abnormality of T cell number (HP:0011839) | 1.90443169 |
| 105 | Chest pain (HP:0100749) | 1.90094293 |
| 106 | Periodontitis (HP:0000704) | 1.90001392 |
| 107 | Vertebral compression fractures (HP:0002953) | 1.89981187 |
| 108 | Encephalitis (HP:0002383) | 1.89277317 |
| 109 | Viral hepatitis (HP:0006562) | 1.88447082 |
| 110 | Achilles tendon contracture (HP:0001771) | 1.88270681 |
| 111 | Polycythemia (HP:0001901) | 1.87988281 |
| 112 | Loss of speech (HP:0002371) | 1.87008938 |
| 113 | T lymphocytopenia (HP:0005403) | 1.86481767 |
| 114 | Arthralgia (HP:0002829) | 1.85738182 |
| 115 | Increased serum ferritin (HP:0003281) | 1.85699560 |
| 116 | Keratoconjunctivitis sicca (HP:0001097) | 1.83344242 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 1.82793601 |
| 118 | Abnormality of the pericardium (HP:0001697) | 1.81510722 |
| 119 | Acrocyanosis (HP:0001063) | 1.81404272 |
| 120 | Hyperparathyroidism (HP:0000843) | 1.79634834 |
| 121 | Urethral obstruction (HP:0000796) | 1.79560839 |
| 122 | Lymphopenia (HP:0001888) | 1.78398731 |
| 123 | Papilloma (HP:0012740) | 1.78172617 |
| 124 | Verrucae (HP:0200043) | 1.78172617 |
| 125 | Polygenic inheritance (HP:0010982) | 1.77361478 |
| 126 | Protrusio acetabuli (HP:0003179) | 1.77190809 |
| 127 | Skin ulcer (HP:0200042) | 1.76963555 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.75734839 |
| 129 | Disproportionate tall stature (HP:0001519) | 1.75460217 |
| 130 | Squamous cell carcinoma (HP:0002860) | 1.73266835 |
| 131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70942818 |
| 132 | Abnormality of T cell physiology (HP:0011840) | 1.70548737 |
| 133 | Broad face (HP:0000283) | 1.69483763 |
| 134 | Slow saccadic eye movements (HP:0000514) | 1.68894474 |
| 135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.66731623 |
| 136 | Recurrent sinusitis (HP:0011108) | 1.63959512 |
| 137 | Abnormality of the pleura (HP:0002103) | 1.63813663 |
| 138 | Glomerulopathy (HP:0100820) | 1.62904261 |
| 139 | Sepsis (HP:0100806) | 1.62687810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.03532570 |
| 2 | PRPF4B | 3.88110739 |
| 3 | MAP3K14 | 3.43489925 |
| 4 | MAP4K1 | 3.25688788 |
| 5 | TBK1 | 2.80346814 |
| 6 | TYK2 | 2.69291613 |
| 7 | MAPK15 | 2.66207108 |
| 8 | RIPK4 | 2.65500407 |
| 9 | IRAK3 | 2.32494525 |
| 10 | BLK | 2.25918440 |
| 11 | IKBKB | 2.24846235 |
| 12 | STK10 | 2.09835452 |
| 13 | JAK1 | 2.03925349 |
| 14 | SIK1 | 2.01936612 |
| 15 | IKBKE | 1.93650686 |
| 16 | CSF1R | 1.91897520 |
| 17 | NME2 | 1.88913053 |
| 18 | EPHB1 | 1.88613048 |
| 19 | JAK3 | 1.87486981 |
| 20 | TAOK2 | 1.85931960 |
| 21 | IRAK4 | 1.85781964 |
| 22 | MAP3K13 | 1.73518762 |
| 23 | TXK | 1.69115109 |
| 24 | CSK | 1.68875398 |
| 25 | ITK | 1.64656221 |
| 26 | CHUK | 1.60871691 |
| 27 | ZAP70 | 1.57408031 |
| 28 | AKT3 | 1.53511428 |
| 29 | SMG1 | 1.53063608 |
| 30 | BMPR2 | 1.52103621 |
| 31 | ERN1 | 1.48030357 |
| 32 | MAP3K10 | 1.44863802 |
| 33 | HCK | 1.44754748 |
| 34 | FGFR4 | 1.30800403 |
| 35 | EPHA3 | 1.30634360 |
| 36 | KIT | 1.26154325 |
| 37 | FES | 1.25379291 |
| 38 | TRIB3 | 1.23470612 |
| 39 | RIPK1 | 1.21684895 |
| 40 | MST4 | 1.21565225 |
| 41 | TSSK6 | 1.20973760 |
| 42 | SIK3 | 1.20910361 |
| 43 | RPS6KA4 | 1.17114331 |
| 44 | TEC | 1.16524188 |
| 45 | IRAK2 | 1.14154369 |
| 46 | MAP2K3 | 1.13821704 |
| 47 | MAP3K3 | 1.12818116 |
| 48 | SIK2 | 1.11374033 |
| 49 | GRK7 | 1.10861233 |
| 50 | MAP3K11 | 1.09799183 |
| 51 | FGFR3 | 1.09681570 |
| 52 | PAK4 | 1.08685687 |
| 53 | LCK | 1.08395512 |
| 54 | BTK | 1.08289540 |
| 55 | PTK6 | 1.06588573 |
| 56 | NLK | 1.06011382 |
| 57 | CLK1 | 1.05408291 |
| 58 | GRK6 | 1.05032385 |
| 59 | LRRK2 | 1.03836061 |
| 60 | DDR2 | 0.99342937 |
| 61 | SYK | 0.99337420 |
| 62 | CDC42BPA | 0.98203223 |
| 63 | NEK9 | 0.96841212 |
| 64 | MOS | 0.96025574 |
| 65 | PRKG2 | 0.95585736 |
| 66 | PIM2 | 0.95571417 |
| 67 | MARK3 | 0.94442925 |
| 68 | DMPK | 0.93890456 |
| 69 | EPHA2 | 0.93681735 |
| 70 | PIM1 | 0.92792968 |
| 71 | JAK2 | 0.92687959 |
| 72 | LATS2 | 0.90793524 |
| 73 | CDK12 | 0.85316955 |
| 74 | TTN | 0.83647889 |
| 75 | FGR | 0.81057892 |
| 76 | EEF2K | 0.77185803 |
| 77 | LYN | 0.72782369 |
| 78 | HIPK2 | 0.72500483 |
| 79 | RPS6KL1 | 0.72325767 |
| 80 | RPS6KC1 | 0.72325767 |
| 81 | ICK | 0.71553437 |
| 82 | CDK6 | 0.70543948 |
| 83 | PKN2 | 0.69884406 |
| 84 | MAP2K2 | 0.69694245 |
| 85 | TAOK1 | 0.68838316 |
| 86 | PAK2 | 0.68483534 |
| 87 | MAPKAPK2 | 0.68251739 |
| 88 | BRAF | 0.64512510 |
| 89 | CDK9 | 0.63451054 |
| 90 | STK11 | 0.59444863 |
| 91 | ALK | 0.58032413 |
| 92 | PDGFRB | 0.57388971 |
| 93 | PDPK1 | 0.56675296 |
| 94 | KSR2 | 0.56619203 |
| 95 | MTOR | 0.55942000 |
| 96 | PDK2 | 0.55904994 |
| 97 | CDK4 | 0.55835168 |
| 98 | IRAK1 | 0.55696322 |
| 99 | BMX | 0.55164493 |
| 100 | STK24 | 0.54913026 |
| 101 | ABL2 | 0.54097308 |
| 102 | ARAF | 0.51968250 |
| 103 | ABL1 | 0.51333495 |
| 104 | CAMK1D | 0.50723253 |
| 105 | MATK | 0.50596892 |
| 106 | PDGFRA | 0.49554064 |
| 107 | MAPKAPK3 | 0.49217807 |
| 108 | TAOK3 | 0.48981554 |
| 109 | BRD4 | 0.48544345 |
| 110 | INSR | 0.46039235 |
| 111 | RPS6KB2 | 0.45729014 |
| 112 | MAPK12 | 0.44959661 |
| 113 | MAP3K8 | 0.44206322 |
| 114 | TRPM7 | 0.43240590 |
| 115 | PTK2B | 0.42990271 |
| 116 | PRKAA2 | 0.42483888 |
| 117 | EGFR | 0.42119023 |
| 118 | RPS6KA1 | 0.42053953 |
| 119 | PRKD2 | 0.41813918 |
| 120 | GSK3A | 0.41668474 |
| 121 | MAPK11 | 0.41557856 |
| 122 | RPS6KA2 | 0.41086876 |
| 123 | MAP3K7 | 0.40025642 |
| 124 | MAP3K9 | 0.39878415 |
| 125 | PRKCQ | 0.38965106 |
| 126 | PKN1 | 0.38600749 |
| 127 | PRKD1 | 0.38492689 |
| 128 | MAPK4 | 0.37674194 |
| 129 | MAPK7 | 0.37094125 |
| 130 | MAP3K1 | 0.36383764 |
| 131 | MELK | 0.35579353 |
| 132 | CAMK1G | 0.35205796 |
| 133 | PDK1 | 0.32529399 |
| 134 | DYRK1B | 0.32205240 |
| 135 | RPS6KA6 | 0.31885825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.65755646 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57446762 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27426716 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22311379 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93286010 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89648461 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81282854 |
| 8 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.78262399 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76368205 |
| 10 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.76328835 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.74203752 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73654600 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69625856 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.68302414 |
| 15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67723307 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63871436 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.60549130 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.60381434 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58824015 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.55283830 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.53214836 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.52081302 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52003700 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47427171 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43849595 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.38759969 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.38138501 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37637287 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.36710948 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.31965060 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31507009 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.31463263 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29429746 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.27896609 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24075535 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.21766122 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.21598172 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.20835879 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.20438586 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17920503 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17689141 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17552345 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17072781 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16698605 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 1.11834240 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11680763 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08742928 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07497180 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.04216880 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01195346 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00700142 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94058122 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93377213 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.92875106 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92765185 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.90470753 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89827106 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89076080 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89019955 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.88001838 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87349617 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.83598519 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.81414761 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.78509400 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78370643 |
| 66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77028029 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76000187 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75834323 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.75676292 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74593430 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74378929 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74325324 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72018064 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.71631370 |
| 75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70968847 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.70653741 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69162530 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68978400 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68755414 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68331337 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.66997886 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65171876 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64675956 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63989661 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62069476 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61383852 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60890642 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59903092 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.58845189 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58652311 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56286396 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55980962 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55819036 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55756495 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55513891 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.55300515 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.54941953 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54690379 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.54672387 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53233992 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52680958 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.51198823 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.50729495 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49691605 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49147281 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48209105 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46781840 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46565382 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46085619 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43287342 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39958620 |

